We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
Product News

BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization

BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization
Product News

BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "BioDiscovery Releases NEXUS CGH Version 2 for DNA Copy Number Analysis and Visualization"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioDiscovery, Inc. has announced the release of NEXUS CGH version 2, the first commercial software tool that can provide easy and powerful platform independent and cross-platform analysis of multiple array based DNA copy number data sets, simultaneously.

NEXUS CGH supports large-scale array experiments involving thousands of samples from any platform, including high-density multi-million probe SNP as well as two-color CGH arrays. Its user-friendly interface, allows the researcher to identify potential regions of significant copy number changes in various biological categories and extract a gene list for the smallest region of overlap in the sample set.

"Using NEXUS CGH, my lab has been able to quickly and confidently process large amounts of high-density array CGH data obtained from FFPE tumor samples to identify important chromosomal regions," said Dr. Jeff Gregg head of Molecular Pathology at UC Davis.

"NEXUS CGH has allowed us to move from raw data into exploring CNV's and associated genes in a matter of few hours whereas this process took months to complete with other commercial or academic packages," Dr. Gregg added.

Dr. Anjene Addington, Child Psychiatry Branch, NIMH, NIH said, "With Nexus CGH, we are able to quickly and easily identify key regions of interest and jump straight to relevant statistical tests and bioinformatics tools, making the whole process more efficient."

Advertisement